Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.6M Sell
1,977,411
-66,936
-3% -$1.75M 0.18% 109
2026
Q1
$57.4M Sell
2,044,347
-129,035
-6% -$3.44M 0.23% 89
2025
Q4
$54.1M Sell
2,173,382
-111,847
-5% -$2.82M 0.2% 103
2025
Q3
$58.2M Buy
2,285,229
+134,516
+6% +$3.32M 0.21% 98
2025
Q2
$52.1M Buy
2,150,713
+178,799
+9% +$4.17M 0.19% 101
2025
Q1
$50M Sell
1,971,914
-28,748
-1% -$752K 0.21% 100
2024
Q4
$53.1M Sell
2,000,662
-54,636
-3% -$1.48M 0.21% 91
2024
Q3
$59.5M Sell
2,055,298
-48,040
-2% -$1.4M 0.23% 93
2024
Q2
$58.9M Sell
2,103,338
-3,380
-0.2% -$93.1K 0.23% 91
2024
Q1
$58.5M Sell
2,106,718
-112,514
-5% -$3.12M 0.23% 102
2023
Q4
$63.9M Sell
2,219,232
-2,747
-0.1% -$83K 0.27% 83
2023
Q3
$73.7M Sell
2,221,979
-33,013
-1% -$1.17M 0.33% 63
2023
Q2
$82.7M Sell
2,254,992
-142,482
-6% -$5.55M 0.35% 56
2023
Q1
$97.8M Sell
2,397,474
-142,232
-6% -$6.14M 0.42% 42
2022
Q4
$130M Buy
2,539,706
+122,997
+5% +$5.9M 0.59% 25
2022
Q3
$106M Buy
2,416,709
+3,937
+0.2% +$191K 0.5% 33
2022
Q2
$127M Buy
2,412,772
+53,597
+2% +$2.73M 0.57% 27
2022
Q1
$122M Buy
2,359,175
+359,823
+18% +$18.7M 0.45% 38
2021
Q4
$118M Buy
1,999,352
+192,751
+11% +$9.55M 0.41% 46
2021
Q3
$77.7M Sell
1,806,601
-106,444
-6% -$4.72M 0.29% 76
2021
Q2
$74.9M Sell
1,913,045
-84,043
-4% -$3.27M 0.27% 84
2021
Q1
$72.4M Sell
1,997,088
-263,833
-12% -$9.37M 0.27% 82
2020
Q4
$83.2M Sell
2,260,921
-346,112
-13% -$12.7M 0.32% 70
2020
Q3
$90.8M Sell
2,607,033
-206,544
-7% -$7.24M 0.38% 50
2020
Q2
$87.3M Sell
2,813,577
-301,129
-10% -$10.2M 0.38% 57
2020
Q1
$96.5M Buy
3,114,706
+544,216
+21% +$18.5M 0.51% 42
2019
Q4
$95.6M Sell
2,570,490
-282,692
-10% -$10.1M 0.4% 53
2019
Q3
$97.3M Sell
2,853,182
-186,046
-6% -$6.77M 0.43% 53
2019
Q2
$125M Sell
3,039,228
-93,181
-3% -$3.7M 0.56% 36
2019
Q1
$126M Sell
3,132,409
-25,459
-0.8% -$1.02M 0.57% 33
2018
Q4
$131M Buy
3,157,868
+47,597
+2% +$1.98M 0.66% 27
2018
Q3
$130M Sell
3,110,271
-315,408
-9% -$12.1M 0.57% 30
2018
Q2
$118M Sell
3,425,679
-180,173
-5% -$6.16M 0.51% 34
2018
Q1
$121M Sell
3,605,852
-245,760
-6% -$8.45M 0.54% 33
2017
Q4
$132M Sell
3,851,612
-94,186
-2% -$3.21M 0.57% 29
2017
Q3
$134M Buy
3,945,798
+1,519
+0% +$48.8K 0.57% 29
2017
Q2
$126M Sell
3,944,279
-325,943
-8% -$10.3M 0.56% 29
2017
Q1
$139M Sell
4,270,222
-88,634
-2% -$2.79M 0.6% 28
2016
Q4
$134M Sell
4,358,856
-51,818
-1% -$1.58M 0.59% 30
2016
Q3
$142M Sell
4,410,674
-115,442
-3% -$3.86M 0.63% 31
2016
Q2
$151M Sell
4,526,116
-113,121
-2% -$3.61M 0.67% 28
2016
Q1
$130M Buy
4,639,237
+90,512
+2% +$2.59M 0.59% 35
2015
Q4
$139M Buy
4,548,725
+46,481
+1% +$1.46M 0.62% 34
2015
Q3
$134M Sell
4,502,244
-53,366
-1% -$1.71M 0.64% 32
2015
Q2
$145M Sell
4,555,610
-129,292
-3% -$4.21M 0.64% 27
2015
Q1
$155M Sell
4,684,902
-127,929
-3% -$4.07M 0.68% 24
2014
Q4
$142M Sell
4,812,831
-104,708
-2% -$3M 0.62% 28
2014
Q3
$138M Hold
4,917,539
0.61% 29
2014
Q2
$138M Sell
4,917,539
-493,350
-9% -$14.1M 0.62% 27
2014
Q1
$165M Sell
5,410,889
-216,051
-4% -$6.44M 0.74% 19
2013
Q4
$164M Sell
5,626,940
-535,662
-9% -$15.6M 0.74% 19
2013
Q3
$168M Sell
6,162,602
-941,463
-13% -$25.6M 0.74% 20
2013
Q2
$189M Buy
+7,104,065
New +$196M 0.81% 17

Other funds holding PFE

STRS Ohio's PFE Position: Q2 2026 in Review

STRS Ohio reduced its Pfizer (PFE) stake by 3.3% in Q2 2026, selling an estimated $1.75M and leaving 1,977,411 shares worth $47.6M. The position accounts for 0.18% of the portfolio, ranked #109.

STRS Ohio first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $189M in Q2 2013. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • STRS Ohio held 1,977,411 shares of Pfizer worth $47.6M as of Q2 2026.
  • STRS Ohio sold 66,936 Pfizer shares in Q2 2026, an estimated $1.75M.
  • Pfizer made up 0.18% of STRS Ohio's portfolio in Q2 2026, its #109 holding.
  • STRS Ohio first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • STRS Ohio's Pfizer position peaked at $189M in Q2 2013.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.